AbbVie
ABBV
#31
Rank
$302.21 B
Marketcap
$171.14
Share price
-2.36%
Change (1 day)
25.30%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of March 2024 : $18.06 B

According to AbbVie's latest financial reports the company has $18.06 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$12.81 B38.87%
2022-12-31$9.22 B-6.11%
2021-12-31$9.83 B15.93%
2020-12-31$8.47 B-78.76%
2019-12-31$39.92 B395.27%
2018-12-31$8.06 B-17.65%
2017-12-31$9.78 B52.41%
2016-12-31$6.42 B-23.6%
2015-12-31$8.40 B0.39%
2014-12-31$8.37 B-15.37%
2013-12-31$9.89 B24.06%
2012-12-31$7.97 B1121.44%
2011-12-31$0.65 B5960.32%
2010-12-31$10.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$11.92 B-33.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.67 B-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.58 B-85.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.70 B-46.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.71 B-73.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.07 B-94.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.17 B-71.36%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.02 B-55.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
$1.21 B-93.30%๐Ÿ‡บ๐Ÿ‡ธ USA